1 Ref: CK-18-0000-AFD(AC)-L-0022 May 15, 2018 Subject: Clarification on Operating Result and Financial Position for the three-month ended March 31, 2018 Attention: President The Stock Exchange of
/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
ที่ FPI Ref. FPI.024/2018 12 November 2018 Subject : Management Discussion & Analysis of Performance Results of Quarter 3/2018 To : Board of Directors and President of The Stock Exchange of Thailand
Page 1 of 4 No. RJH – SET 16/2019 11 November 2019 Subject : Management’s Discussion and Analysis for the 3rd Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital
Microsoft Word - MDA Q319 EN.docx November 11, 2019 To President The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20 percent
Attention: President The Stock Exchange of Thailand Regarding to JAS Asset Public Company Limited (“the Company”) Board of Meeting No.4/2020 on 15 May 2020, the resolution to certify the Company’s financial
Microsoft Word - MDA Q220 EN August 10, 2020 To President The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20 percent
Subject Management Discussion and Analysis for the second quarter ended 30 June 2020 Attention President The Stock Exchange of Thailand According to the resolution of the Board of Directors of JAS Asset
ที่ FPI Ref. FPI.008/2020 11 August 2020 Subject : Management Discussion & Analysis of Performance Results of Quarter 2 2020 To : Board of Directors and President of The Stock Exchange of Thailand
Q2/2020 (Ending June 30, 2020) To Director and Manager of the Stock Exchange of Thailand UBIS (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial